12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, health care stocks saw significant movements with CytomX Therapeutics, ZimVie, and Aesthetic Medical Intl leading the gains, while Etao International, Enhabit, and Myomo were among the top losers. Most movements were influenced by the release of Q1 earnings.
May 08, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CytomX Therapeutics stock surged 87.1% to $7.84 after Q1 earnings, with a market value of $534.1 million.
The significant surge in CTMX's stock price is directly attributed to the positive reception of their Q1 earnings report.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
ZimVie shares increased by 17.03% to $18.0 after Q1 earnings, with a market cap of $489.9 million.
ZimVie's stock price increase is a direct result of the market's positive reaction to their Q1 earnings announcement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85
NEGATIVE IMPACT
Enhabit stock decreased by 13.1% to $8.43, with a market value of $422.8 million, following Q1 earnings.
The decline in EHAB's stock price can be attributed to the market's negative response to their Q1 earnings.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85
NEGATIVE IMPACT
Exact Sciences shares decreased by 10.11% to $53.47, with a market value of $9.8 billion, after Q1 earnings.
Exact Sciences' stock price drop is linked to the market's reaction to their Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85